Research hot spots of ophthalmology-related coronavirus disease 2019_Chinese Journal of Ocular Fundus Diseases

Authors：

Liu Yan , Wang Xiuhua , Ming Shuai ,  Lei Bo , Yin Weijing

Henan Provincial People's Hospital, Henan Eye Hospital, Henan Eye Institute, Zhengzhou 450003, China;
Lei Bo and Yin Weijing are contributed equally to the article;

Corresponding?author：

Lei Bo, Email: bolei99@126.com

Keywords：

Ophthalmology; Bibliometrics; COVID-19; SARS-CoV-2

DOI：

10.3760/cma.j.cn511434-20220317-00152

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To study the research hot spots of ophthalmology-related coronavirus disease 2019 (COVID-19). Methods PubMed database as the data source, the literatures of ophthalmology-related COVID-19 published on January 1, 2020 to February 22, 2022 were collected, limited to Medline included, the language type was limited to English and Chinese, and 1 592 literatures were included. By reading the titles and abstracts, the literatures of meeting notice, editor's note, etc. and the literature that was not quite relevant with ophthalmology-related COVID-19 were removed, and finally 1 547 literatures were included. Bibliographic Items Co-occurrence Matrix Builder (BICOMB 2.02 software) was used to collect the frequency of major Mesh terms/subheadings and the frequency of major Mesh terms after removing the subheadings, and the number of included articles published in the top 10 journals by the number of ophthalmology-related COVID-19 articles was recorded. VosViewer 1.6.18 software was used for cluster analysis of collaborator network and major Mesh terms, and the publication status and country or region distribution of active authors of ophthalmology-related COVID-19 were recorded. Results Of the 1 547 literatures, the active authors were mainly from India, Italy, Singapore, Spain, and Hong Kong, China, and so on; the top 10 journals published 617 articles in total (39.88%, 617/1 547). The high frequency major Mesh terms/subheadings included COVID-19, viral pneumonia, coronavirus infection, eye diseases/epidemiology, complications, prevention & control, diagnosis, virology, and Severe acute respiratory syndrome coronavirus 2, betacoronavirus/isolation & purification, ophthalmology/education, organization & administration, telemedicine, delivery of health care/organization & administration, and mucormycosis/diagnosis, etc. After taking out the subheadings, the high frequency of major Mesh terms also included conjunctivitis, orbital disease, retinal diseases, neuromyelitis optica, retinal vein occlusion, myopia and other eye diseases, eye diseases-related systemic diseases, such as multiple sclerosis and Miller Fisher syndrome, therapy and prevention-related drugs, such as hydroxyl chloroquine, angiogenesis inhibitors, and vaccination. Conclusions Ophthalmology-related COVID-19 researches have received extensive attention worldwide, COVID-19 is associated with multiple ocular diseases of anterior and posterior segments. COVID-19-related mucormycosis, hydroxychloroquine and possible retinal toxicity, and possible ocular adverse effects associated with vaccination are also noteworthy.

Citation： Liu Yan, Wang Xiuhua, Ming Shuai, Lei Bo, Yin Weijing. Research hot spots of ophthalmology-related coronavirus disease 2019. Chinese Journal of Ocular Fundus Diseases, 2022, 38(7): 593-600. doi: 10.3760/cma.j.cn511434-20220317-00152 Copy

1.	Sen M, Honavar SG, Sharma N, et al. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19[J]. Indian J Ophthalmol, 2021, 69(3): 488-509. DOI: 10.4103/ijo.IJO_297_21.
2.	尹勝杰, 張銘志. 暴發性流行性疾病病毒傳播途徑與眼病[J]. 中華實驗眼科雜志, 2020, 38(2): 156-160. DOI: 10.3760/cma.j.issn.2095-0160.2020.02.014.Yin SJ, Zhang MZ. New coronavirus pneumonia and outbreak epidemic virus and eye disease[J]. Chin J Exp Ophthalmol, 2020, 38(2): 156-160. DOI: 10.3760/cma.j.issn.2095-0160.2020.02.014.
3.	葉婭, 宋艷萍, 閆明, 等. 新型冠狀病毒肺炎合并結膜炎三例[J]. 中華實驗眼科雜志, 2020, 38(3): 242-244. DOI: 10.3760/cma.j.issn.2095-0160.2020.0004.Ye Y, Song YP, Yan M, et al. Novel coronavirus pneumonia combined with conjunctivitis: three cases report[J]. Chin J Exp Ophthalmol, 2020, 38(3): 242-244. DOI: 10.3760/cma.j.issn.2095-0160.2020.0004.
4.	徐曼, 張宏達, 牛曉光. 以急性瞼板腺炎和結膜下出血首診于眼科的新型冠狀病毒肺炎一例[J]. 中華實驗眼科雜志, 2020, 38(4): 374-376. DOI: 10.3760/cma.j.cn115989-20200228-00121.Xu M, Zhang HD, Niu XG, et al. COVID-19 patient firstly visiting eye doctor due to tarsadenitis and subconjunctival hemorrhage: a case report[J]. Chin J Exp Ophthalmol, 2020, 38(4): 374-376. DOI: 10.3760/cma.j.cn115989-20200228-00121.
5.	Tang SWK, Romano MR, Wong D, et al. The use of personal protective equipment in clinical ophthalmology during corona virus disease-2019: a review of international guidelines and literature[J]. Curr Opin Ophthalmol, 2020, 31(5): 435-446. DOI: 10.1097/ICU.0000000000000691.
6.	Succar T, Beaver HA, Lee AG. Impact of COVID-19 pandemic on ophthalmology medical student teaching: educational innovations, challenges, and future directions[J]. Surv Ophthalmol, 2022, 67(1): 217-225. DOI: 10.1016/j.survophthal.2021.03.011.
7.	Parke DW 2nd. COVID-19 era impacts on the American Academy of Ophthalmology[J]. Ophthalmology, 2020, 127(11): 1447-1450. DOI: 10.1016/j.ophtha.2020.07.056.
8.	Pasricha ND, Haq Z, Ahmad TR, et al. Remote corneal suturing wet lab: microsurgical education during the COVID-19 pandemic[J]. J Cataract Refract Surg, 2020, 46(12): 1667-1673. DOI: 10.1097/j.jcrs.0000000000000374.
9.	李志杰. 眼科醫生和研究人員如何理解和應對新型冠狀病毒肺炎的流行[J]. 中華實驗眼科雜志, 2020, 38(3): 267-272. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.010.Li ZJ. How ophthalmologists should understand and respond to the current epidemic of novel coronavirus pneumonia[J]. Chin J Exp Ophthalmol, 2020, 38(3): 267-272. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.010.
10.	黎曉新, 林寶嬌, 陳燕芒, 等. 新型冠狀病毒肺炎疫情期間眼科臨床診療工作防控措施及崗位流程[J]. 中華實驗眼科雜志, 2020, 38(3): 261-266. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.007.Li XX, Lin BJ, Chen YM, et al. Prevention and control measures and job procedures for ophthalmology clinical diagnosis and treatment during the novel coronavirus pneumonia epidemic[J]. Chin J Exp Ophthalmol, 2020, 38(3): 261-266. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.007.
11.	王曉蕾, 王貞, 姚春蓮, 等. 新型冠狀病毒肺炎疫情下眼科患者圍手術期管理實踐[J]. 中華實驗眼科雜志, 2020, 38(3): 200-203. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.016.Wang XL, Wang Z, Yao CL, et al. Management of ophthalmic perioperative period during 2019 novel coronavirus disease outbreak[J]. Chin J Exp Ophthalmol, 2020, 38(3): 200-203. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.016.
12.	高正, 王曉幸, 黃小明, 等. 新型冠狀病毒肺炎疫情防控期間眼科遠程專屬醫生平臺的構建和應用價值[J]. 中華實驗眼科雜志, 2020, 38(4): 305-310. DOI: 10.3760/cma.j.cn115989-20200306-00149.Gao Z, Wang XX, Huang XM, et al. Development of a remote dedicated doctor platform of ophthalmology and its application efficiency during epidemic of COVID-19[J]. Chin J Exp Ophthalmol, 2020, 38(4): 305-310. DOI: 10.3760/cma.j.cn115989-20200306-00149.
13.	張璐佳, 靳秀秀, 雷博. 新型冠狀病毒關鍵受體ACE2在眼部的分布及其臨床意義[J]. 中華實驗眼科雜志, 2020, 38(5): 463-467. DOI: 10.3760/cma.j.cn115989-20200316-00173.Zhang LJ, Jin XX, Lei B. Distribution and clinical significance of ACE2, a key receptor of 2019-nCoV, in ocular tissues[J]. Chin J Exp Ophthalmol, 2020, 38(5): 463-467. DOI: 10.3760/cma.j.cn115989-20200316-00173.
14.	Deng W, Bao L, Gao H, et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques[J/OL]. Nat Commun, 2020, 11(1): 4400[2022-03-08]. https://pubmed.ncbi.nlm.nih.gov/32879306/. DOI: 10.1038/s41467-020-18149-6.
15.	Savastano MC, Gambini G, Savastano A, et al. Evidence-based of conjunctival COVID-19 positivity: an Italian experience: Gemelli Against COVID Group[J]. Eur J Ophthalmol, 2021, 31(6): 2886-2893. DOI: 10.1177/1120672120976548.
16.	Arora R, Goel R, Kumar S, et al. Evaluation of SARS-CoV-2 in tears of patients with moderate to severe COVID-19[J]. Ophthalmology, 2021, 128(4): 494-503. DOI: 10.1016/j.ophtha.2020.08.029.
17.	Sawant OB, Singh S, Wright RE, et al. Prevalence of SARS-CoV-2 in human post-mortem ocular tissues[J]. Ocul Surf, 2021, 19: 322-329. DOI: 10.1016/j.jtos.2020.11.002.
18.	Bilgic A, Sudhalkar A, Gonzalez-Cortes JH, et al. Endogenous endophthalmitis in the setting of COVID-19 infection: a case series[J]. Retina, 2021, 41(8): 1709-1714. DOI: 10.1097/IAE.0000000000003168.
19.	Araujo-Silva CA, Marcos A, Marinho PM, et al. Presumed SARS-CoV-2 viral particles in the human retina of patients with COVID-19[J]. JAMA Ophthalmol, 2021, 139(9): 1015-1021. DOI: 10.1001/jamaophthalmol.2021.2795.
20.	Bernabei F, Versura P, Rossini G, et al. There is a role in detection of SARS-CoV-2 in conjunctiva and tears: a comprehensive review[J]. New Microbiol, 2020, 43(4): 149-155.
21.	Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals[J]. Ocul Immunol Inflamm, 2020, 28(3): 391-395. DOI: 10.1080/09273948.2020.1738501.
22.	Marinho PM, Marcos AAA, Romano AC, et al. Retinal findings in patients with COVID-19[J]. Lancet, 2020, 395(10237): 1610. DOI: 10.1016/S0140-6736(20)31014-X.
23.	Sen S, Kannan NB, Kumar J, et al. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review[J]. Int Ophthalmol, 2022, 42(1): 323-336. DOI: 10.1007/s10792-021-01996-7.
24.	Künzel SE, Bürgel T, Künzel SH, et al. Low vulnerability of the posterior eye segment to SARS-COV-2 infection: chorioretinal SARS-CoV-2 vulnerability[J]. Retina, 2022, 42(2): 236-243. DOI: 10.1097/IAE.0000000000003320.
25.	Cennamo G, Reibaldi M, Montorio D, et al. Optical coherence tomography angiography features in post-COVID-19 pneumonia patients: a pilot study[J]. Am J Ophthalmol, 2021, 227: 182-190. DOI: 10.1016/j.ajo.2021.03.015.
26.	劉佩, 宋沉生, 吳松笛. 新型冠狀病毒病神經眼科表現的研究現狀[J]. 中華眼底病雜志, 2021, 37(10): 812-817. DOI: 10.3760/cma.j.cn511434-20210513-00252.Liu P, Song CS, Wu SD. Reserch progress of neuro-ophthalmic manifestations of coronavirus disease 2019[J]. Chin J Ocul Fundus Dis, 2021, 37(10): 812-817. DOI: 10.3760/cma.j.cn511434-20210513-00252.
27.	Saldanha IJ, Petris R, Makara M, et al. Impact of the COVID-19 pandemic on eye strain and dry eye symptoms[J]. Ocul Surf, 2021, 22: 38-46. DOI: 10.1016/j.jtos.2021.06.004.
28.	于薏, 周奕文, 萬珊珊, 等. 新型冠狀病毒肺炎疫情期間心理健康對干眼的影響及防控[J]. 中華實驗眼科雜志, 2020, 38(5): 468-472. DOI: 10.3760/cma.j.cn115989-20200322-00192.Yu Y, Zhou YW, Wan SS, et al. Impact of psychological health on dry eye and management during the coronavirus disease-19 epidemic[J]. Chin J Exp Ophthalmol, 2020, 38(5): 468-472. DOI: 10.3760/cma.j.cn115989-20200322-00192.
29.	張海, 劉鋼, 杭偉, 等. 鼻眶腦型毛霉菌病九例[J]. 中華耳鼻咽喉頭頸外科雜志, 2014, 49(6): 446-451. DOI: 10.3760/cma.j.issn.1673-0860.2014.06.002.Zhang H, Liu G, Hang W, et al. Rhino-orbito-cerebral mucormycosis: report of 9 cases[J]. Chin J Otorhinolaryngol Head Neck Surg, 2014, 49(6): 446-451. DOI: 10.3760/cma.j.issn.1673-0860.2014.06.002.
30.	Thakar A, Lal D. "Black fungus": a perspective on the coronavirus disease 2019 (COVID-19)-associated rhino-orbital mucormycosis epidemic in India[J]. Int Forum Allergy Rhinol, 2021, 11(8): 1278-1279. DOI: 10.1002/alr.22855.
31.	Ravani SA, Agrawal GA, Leuva PA, et al. Rise of the phoenix: mucormycosis in COVID-19 times[J]. Indian J Ophthalmol, 2021, 69(6): 1563-1568. DOI: 10.4103/ijo.IJO_310_21.
32.	Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity[J]. Science, 2020, 370(6518): 856-860. DOI: 10.1126/science.abd2985.
33.	Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020, 181(2): 271-280. DOI: 10.1016/j.cell.2020.02.052.
34.	Yao Y, Ma D, Xu Y, et al. Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells[J/OL]. Exp Eye Res, 2022, 214: 108864[2021-11-24]. https://pubmed.ncbi.nlm.nih.gov/34826419/. DOI: 10.1016/j.exer.2021.108864.
35.	Nicolò M, Ferro Desideri L, Bassetti M, et al. Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak[J]. Int Ophthalmol, 2021, 41(2): 719-725. DOI: 10.1007/s10792-020-01593-0.
36.	Karagöz IK, Munk MR, Kaya M, et al. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?[J/OL]. Exp Eye Res, 2021, 203: 108433[2021-01-02]. https://pubmed.ncbi.nlm.nih.gov/33400927/. DOI: 10.1016/j.exer.2020.108433.
37.	Eleiwa TK, Gaier ED, Haseeb A, et al. Adverse ocular events following COVID-19 vaccination[J]. Inflamm Res, 2021, 70(10-12): 1005-1009. DOI: 10.1007/s00011-021-01506-6.
38.	Jampol LM, Tauscher R, Schwarz HP. COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence?[J]. JAMA Ophthalmol, 2021, 139(10): 1135-1136. DOI: 10.1001/jamaophthalmol.2021.3483.

1. Sen M, Honavar SG, Sharma N, et al. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19[J]. Indian J Ophthalmol, 2021, 69(3): 488-509. DOI: 10.4103/ijo.IJO_297_21.
2. 尹勝杰, 張銘志. 暴發性流行性疾病病毒傳播途徑與眼病[J]. 中華實驗眼科雜志, 2020, 38(2): 156-160. DOI: 10.3760/cma.j.issn.2095-0160.2020.02.014.Yin SJ, Zhang MZ. New coronavirus pneumonia and outbreak epidemic virus and eye disease[J]. Chin J Exp Ophthalmol, 2020, 38(2): 156-160. DOI: 10.3760/cma.j.issn.2095-0160.2020.02.014.
3. 葉婭, 宋艷萍, 閆明, 等. 新型冠狀病毒肺炎合并結膜炎三例[J]. 中華實驗眼科雜志, 2020, 38(3): 242-244. DOI: 10.3760/cma.j.issn.2095-0160.2020.0004.Ye Y, Song YP, Yan M, et al. Novel coronavirus pneumonia combined with conjunctivitis: three cases report[J]. Chin J Exp Ophthalmol, 2020, 38(3): 242-244. DOI: 10.3760/cma.j.issn.2095-0160.2020.0004.
4. 徐曼, 張宏達, 牛曉光. 以急性瞼板腺炎和結膜下出血首診于眼科的新型冠狀病毒肺炎一例[J]. 中華實驗眼科雜志, 2020, 38(4): 374-376. DOI: 10.3760/cma.j.cn115989-20200228-00121.Xu M, Zhang HD, Niu XG, et al. COVID-19 patient firstly visiting eye doctor due to tarsadenitis and subconjunctival hemorrhage: a case report[J]. Chin J Exp Ophthalmol, 2020, 38(4): 374-376. DOI: 10.3760/cma.j.cn115989-20200228-00121.
5. Tang SWK, Romano MR, Wong D, et al. The use of personal protective equipment in clinical ophthalmology during corona virus disease-2019: a review of international guidelines and literature[J]. Curr Opin Ophthalmol, 2020, 31(5): 435-446. DOI: 10.1097/ICU.0000000000000691.
6. Succar T, Beaver HA, Lee AG. Impact of COVID-19 pandemic on ophthalmology medical student teaching: educational innovations, challenges, and future directions[J]. Surv Ophthalmol, 2022, 67(1): 217-225. DOI: 10.1016/j.survophthal.2021.03.011.
7. Parke DW 2nd. COVID-19 era impacts on the American Academy of Ophthalmology[J]. Ophthalmology, 2020, 127(11): 1447-1450. DOI: 10.1016/j.ophtha.2020.07.056.
8. Pasricha ND, Haq Z, Ahmad TR, et al. Remote corneal suturing wet lab: microsurgical education during the COVID-19 pandemic[J]. J Cataract Refract Surg, 2020, 46(12): 1667-1673. DOI: 10.1097/j.jcrs.0000000000000374.
9. 李志杰. 眼科醫生和研究人員如何理解和應對新型冠狀病毒肺炎的流行[J]. 中華實驗眼科雜志, 2020, 38(3): 267-272. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.010.Li ZJ. How ophthalmologists should understand and respond to the current epidemic of novel coronavirus pneumonia[J]. Chin J Exp Ophthalmol, 2020, 38(3): 267-272. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.010.
10. 黎曉新, 林寶嬌, 陳燕芒, 等. 新型冠狀病毒肺炎疫情期間眼科臨床診療工作防控措施及崗位流程[J]. 中華實驗眼科雜志, 2020, 38(3): 261-266. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.007.Li XX, Lin BJ, Chen YM, et al. Prevention and control measures and job procedures for ophthalmology clinical diagnosis and treatment during the novel coronavirus pneumonia epidemic[J]. Chin J Exp Ophthalmol, 2020, 38(3): 261-266. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.007.
11. 王曉蕾, 王貞, 姚春蓮, 等. 新型冠狀病毒肺炎疫情下眼科患者圍手術期管理實踐[J]. 中華實驗眼科雜志, 2020, 38(3): 200-203. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.016.Wang XL, Wang Z, Yao CL, et al. Management of ophthalmic perioperative period during 2019 novel coronavirus disease outbreak[J]. Chin J Exp Ophthalmol, 2020, 38(3): 200-203. DOI: 10.3760/cma.j.issn.2095-0160.2020.03.016.
12. 高正, 王曉幸, 黃小明, 等. 新型冠狀病毒肺炎疫情防控期間眼科遠程專屬醫生平臺的構建和應用價值[J]. 中華實驗眼科雜志, 2020, 38(4): 305-310. DOI: 10.3760/cma.j.cn115989-20200306-00149.Gao Z, Wang XX, Huang XM, et al. Development of a remote dedicated doctor platform of ophthalmology and its application efficiency during epidemic of COVID-19[J]. Chin J Exp Ophthalmol, 2020, 38(4): 305-310. DOI: 10.3760/cma.j.cn115989-20200306-00149.
13. 張璐佳, 靳秀秀, 雷博. 新型冠狀病毒關鍵受體ACE2在眼部的分布及其臨床意義[J]. 中華實驗眼科雜志, 2020, 38(5): 463-467. DOI: 10.3760/cma.j.cn115989-20200316-00173.Zhang LJ, Jin XX, Lei B. Distribution and clinical significance of ACE2, a key receptor of 2019-nCoV, in ocular tissues[J]. Chin J Exp Ophthalmol, 2020, 38(5): 463-467. DOI: 10.3760/cma.j.cn115989-20200316-00173.
14. Deng W, Bao L, Gao H, et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques[J/OL]. Nat Commun, 2020, 11(1): 4400[2022-03-08]. https://pubmed.ncbi.nlm.nih.gov/32879306/. DOI: 10.1038/s41467-020-18149-6.
15. Savastano MC, Gambini G, Savastano A, et al. Evidence-based of conjunctival COVID-19 positivity: an Italian experience: Gemelli Against COVID Group[J]. Eur J Ophthalmol, 2021, 31(6): 2886-2893. DOI: 10.1177/1120672120976548.
16. Arora R, Goel R, Kumar S, et al. Evaluation of SARS-CoV-2 in tears of patients with moderate to severe COVID-19[J]. Ophthalmology, 2021, 128(4): 494-503. DOI: 10.1016/j.ophtha.2020.08.029.
17. Sawant OB, Singh S, Wright RE, et al. Prevalence of SARS-CoV-2 in human post-mortem ocular tissues[J]. Ocul Surf, 2021, 19: 322-329. DOI: 10.1016/j.jtos.2020.11.002.
18. Bilgic A, Sudhalkar A, Gonzalez-Cortes JH, et al. Endogenous endophthalmitis in the setting of COVID-19 infection: a case series[J]. Retina, 2021, 41(8): 1709-1714. DOI: 10.1097/IAE.0000000000003168.
19. Araujo-Silva CA, Marcos A, Marinho PM, et al. Presumed SARS-CoV-2 viral particles in the human retina of patients with COVID-19[J]. JAMA Ophthalmol, 2021, 139(9): 1015-1021. DOI: 10.1001/jamaophthalmol.2021.2795.
20. Bernabei F, Versura P, Rossini G, et al. There is a role in detection of SARS-CoV-2 in conjunctiva and tears: a comprehensive review[J]. New Microbiol, 2020, 43(4): 149-155.
21. Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals[J]. Ocul Immunol Inflamm, 2020, 28(3): 391-395. DOI: 10.1080/09273948.2020.1738501.
22. Marinho PM, Marcos AAA, Romano AC, et al. Retinal findings in patients with COVID-19[J]. Lancet, 2020, 395(10237): 1610. DOI: 10.1016/S0140-6736(20)31014-X.
23. Sen S, Kannan NB, Kumar J, et al. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review[J]. Int Ophthalmol, 2022, 42(1): 323-336. DOI: 10.1007/s10792-021-01996-7.
24. Künzel SE, Bürgel T, Künzel SH, et al. Low vulnerability of the posterior eye segment to SARS-COV-2 infection: chorioretinal SARS-CoV-2 vulnerability[J]. Retina, 2022, 42(2): 236-243. DOI: 10.1097/IAE.0000000000003320.
25. Cennamo G, Reibaldi M, Montorio D, et al. Optical coherence tomography angiography features in post-COVID-19 pneumonia patients: a pilot study[J]. Am J Ophthalmol, 2021, 227: 182-190. DOI: 10.1016/j.ajo.2021.03.015.
26. 劉佩, 宋沉生, 吳松笛. 新型冠狀病毒病神經眼科表現的研究現狀[J]. 中華眼底病雜志, 2021, 37(10): 812-817. DOI: 10.3760/cma.j.cn511434-20210513-00252.Liu P, Song CS, Wu SD. Reserch progress of neuro-ophthalmic manifestations of coronavirus disease 2019[J]. Chin J Ocul Fundus Dis, 2021, 37(10): 812-817. DOI: 10.3760/cma.j.cn511434-20210513-00252.
27. Saldanha IJ, Petris R, Makara M, et al. Impact of the COVID-19 pandemic on eye strain and dry eye symptoms[J]. Ocul Surf, 2021, 22: 38-46. DOI: 10.1016/j.jtos.2021.06.004.
28. 于薏, 周奕文, 萬珊珊, 等. 新型冠狀病毒肺炎疫情期間心理健康對干眼的影響及防控[J]. 中華實驗眼科雜志, 2020, 38(5): 468-472. DOI: 10.3760/cma.j.cn115989-20200322-00192.Yu Y, Zhou YW, Wan SS, et al. Impact of psychological health on dry eye and management during the coronavirus disease-19 epidemic[J]. Chin J Exp Ophthalmol, 2020, 38(5): 468-472. DOI: 10.3760/cma.j.cn115989-20200322-00192.
29. 張海, 劉鋼, 杭偉, 等. 鼻眶腦型毛霉菌病九例[J]. 中華耳鼻咽喉頭頸外科雜志, 2014, 49(6): 446-451. DOI: 10.3760/cma.j.issn.1673-0860.2014.06.002.Zhang H, Liu G, Hang W, et al. Rhino-orbito-cerebral mucormycosis: report of 9 cases[J]. Chin J Otorhinolaryngol Head Neck Surg, 2014, 49(6): 446-451. DOI: 10.3760/cma.j.issn.1673-0860.2014.06.002.
30. Thakar A, Lal D. "Black fungus": a perspective on the coronavirus disease 2019 (COVID-19)-associated rhino-orbital mucormycosis epidemic in India[J]. Int Forum Allergy Rhinol, 2021, 11(8): 1278-1279. DOI: 10.1002/alr.22855.
31. Ravani SA, Agrawal GA, Leuva PA, et al. Rise of the phoenix: mucormycosis in COVID-19 times[J]. Indian J Ophthalmol, 2021, 69(6): 1563-1568. DOI: 10.4103/ijo.IJO_310_21.
32. Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity[J]. Science, 2020, 370(6518): 856-860. DOI: 10.1126/science.abd2985.
33. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020, 181(2): 271-280. DOI: 10.1016/j.cell.2020.02.052.
34. Yao Y, Ma D, Xu Y, et al. Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells[J/OL]. Exp Eye Res, 2022, 214: 108864[2021-11-24]. https://pubmed.ncbi.nlm.nih.gov/34826419/. DOI: 10.1016/j.exer.2021.108864.
35. Nicolò M, Ferro Desideri L, Bassetti M, et al. Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak[J]. Int Ophthalmol, 2021, 41(2): 719-725. DOI: 10.1007/s10792-020-01593-0.
36. Karagöz IK, Munk MR, Kaya M, et al. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?[J/OL]. Exp Eye Res, 2021, 203: 108433[2021-01-02]. https://pubmed.ncbi.nlm.nih.gov/33400927/. DOI: 10.1016/j.exer.2020.108433.
37. Eleiwa TK, Gaier ED, Haseeb A, et al. Adverse ocular events following COVID-19 vaccination[J]. Inflamm Res, 2021, 70(10-12): 1005-1009. DOI: 10.1007/s00011-021-01506-6.
38. Jampol LM, Tauscher R, Schwarz HP. COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence?[J]. JAMA Ophthalmol, 2021, 139(10): 1135-1136. DOI: 10.1001/jamaophthalmol.2021.3483.

Previous Article
Long-term effectiveness and safety of new channelrhodopsin PsCatCh2.0 in the treatment of retinal degenerative diseases
Next Article
原發于中樞神經系統淋巴瘤的眼內淋巴瘤1例

Chinese Journal of Ocular Fundus Diseases

Research hot spots of ophthalmology-related coronavirus disease 2019

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content